WO2012022796A3 - Neue kombinationen - Google Patents

Neue kombinationen Download PDF

Info

Publication number
WO2012022796A3
WO2012022796A3 PCT/EP2011/064261 EP2011064261W WO2012022796A3 WO 2012022796 A3 WO2012022796 A3 WO 2012022796A3 EP 2011064261 W EP2011064261 W EP 2011064261W WO 2012022796 A3 WO2012022796 A3 WO 2012022796A3
Authority
WO
WIPO (PCT)
Prior art keywords
novel combinations
pharmaceuticals
radicals
besides
contain
Prior art date
Application number
PCT/EP2011/064261
Other languages
English (en)
French (fr)
Other versions
WO2012022796A2 (de
Inventor
Birgit Jung
Angelo Ceci
Henri Doods
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of WO2012022796A2 publication Critical patent/WO2012022796A2/de
Publication of WO2012022796A3 publication Critical patent/WO2012022796A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Abstract

Die vorliegende Erfindung betrifft neue Arzneimittelkombinationen, die neben einer oder mehrerer, bevorzugt einer Verbindung der allgemeinen Formel (I) worin die Reste Y, R1, R2, R3 und R4 die in den Ansprüchen und in der Beschreibung genannten Bedeutungen haben können, wenigstens einen weiteren Wirkstoff II enthalten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel.
PCT/EP2011/064261 2010-08-20 2011-08-19 Neue kombinationen WO2012022796A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10173490 2010-08-20
EP10173490.3 2010-08-20

Publications (2)

Publication Number Publication Date
WO2012022796A2 WO2012022796A2 (de) 2012-02-23
WO2012022796A3 true WO2012022796A3 (de) 2012-04-19

Family

ID=44512885

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/064261 WO2012022796A2 (de) 2010-08-20 2011-08-19 Neue kombinationen

Country Status (1)

Country Link
WO (1) WO2012022796A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2688119T3 (es) * 2015-07-08 2018-10-31 Dr. Falk Pharma Gmbh Formulación farmacéutica para el tratamiento de cambios inflamatorios del recto

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001013953A2 (en) * 1999-08-21 2001-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
WO2005111005A1 (de) * 2004-05-14 2005-11-24 Boehringer Ingelheim International Gmbh Neue enantiomerenreine betaagonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel
EP2025673A1 (de) * 2007-08-14 2009-02-18 Boehringer Ingelheim International GmbH Arylsulfonamide mit analgetischer Wirkung
WO2009098051A1 (de) * 2008-02-06 2009-08-13 Boehringer Ingelheim International Gmbh Arylsulfonamide wirksam als schmerzmittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010001664A (es) 2007-08-14 2010-03-10 Boehringer Ingelheim Int Nuevos compuestos.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001013953A2 (en) * 1999-08-21 2001-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
WO2005111005A1 (de) * 2004-05-14 2005-11-24 Boehringer Ingelheim International Gmbh Neue enantiomerenreine betaagonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel
EP2025673A1 (de) * 2007-08-14 2009-02-18 Boehringer Ingelheim International GmbH Arylsulfonamide mit analgetischer Wirkung
WO2009098051A1 (de) * 2008-02-06 2009-08-13 Boehringer Ingelheim International Gmbh Arylsulfonamide wirksam als schmerzmittel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CAROLA SEIFART: "Emerging drugs in chronic obstructive pulmonary disease", EXPERT OPINION ON EMERGING DRUGS, ASHLEY PUBLICATIONS, GB, vol. 14, 1 January 2009 (2009-01-01), pages 181 - 194, XP009153211, ISSN: 1472-8214 *

Also Published As

Publication number Publication date
WO2012022796A2 (de) 2012-02-23

Similar Documents

Publication Publication Date Title
WO2014097151A3 (en) Autotaxin inhibitors
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
CA2871471C (en) Dna-pk inhibitors
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
MX2013000821A (es) Nuevas aminopirazoloquinazolinas.
MX2013004491A (es) Boronatos como inhibidores de arginasa.
WO2010007116A3 (en) Pyridons as pdk1 inhibitors
MX2015008100A (es) Composiciones que comprenden un compuesto de triazol.
WO2011041461A3 (en) Polycyclic compounds as lysophosphatidic acid receptor antagonists
WO2014007951A3 (en) Substituted tricyclic compounds as fgfr inhibitors
WO2013091775A3 (de) Verwendung von cyclohexanolderivaten als antimikrobielle wirkstoffe
WO2010058032A3 (en) Substituted pyrimidines for the treatment of diseases such as cancer
WO2007025709A3 (en) Organic compounds
WO2013004995A8 (en) Pyrimidinone compounds and their use
WO2010079431A3 (en) Compounds for the prevention and treatment of cardiovascular disease
EP3626253A3 (de) Stabile linaclotidformulierungen
WO2010068292A8 (en) Azaindole derivatives as kinase inhibitors
WO2013061004A8 (fr) Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines
WO2011088027A8 (en) Compounds and methods
WO2011143772A9 (en) Inhibitors of hiv replication
WO2009105969A8 (zh) 埃坡霉素类似物、其药物组合物、用途及其制备方法
WO2013040227A3 (en) Therapeutic compounds
UA111210C2 (uk) Антибактеріальні 3,4-дигідро-1h-[1,8]нафтиридинони, заміщені циклопента[c]піролом
WO2013014204A3 (en) 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
WO2011069037A3 (en) Stabilization and storage of biological pharmaceutical compositions

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11745793

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11745793

Country of ref document: EP

Kind code of ref document: A2